Literature DB >> 12109139

The molecular genetics of lentiviral vectors--current and future perspectives.

L J Chang1, E E Gay.   

Abstract

Gene therapy is a promising endeavor for the treatment of disease in the 21st century. The key to capitalize on this venture lies in the availability of efficient gene transfer and expression tools. Viral vectors are useful vehicles for the delivery of foreign genes into target cells, and retroviral vectors have been popular because of their ability to integrate into the host cell genome and maintain persistent gene expression. Recent studies of the human immunodeficiency virus (HIV) have demonstrated that lentiviruses, members of the retroviral family, have the ability to infect cells at both mitotic and post-mitotic stages of the cell cycle. This article aims to analyze the molecular genetics, review existing systems and applications, and address problems as well as potential future developments of the lentiviral vector systems.

Entities:  

Mesh:

Year:  2001        PMID: 12109139     DOI: 10.2174/1566523013348634

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  19 in total

1.  Development and Validation of a Rex1-RFP Potency Activity Reporter Assay That Quantifies Stress-Forced Potency Loss in Mouse Embryonic Stem Cells.

Authors:  Quanwen Li; Nardhy Gomez-Lopez; Sascha Drewlo; Elly Sanchez-Rodriguez; Jing Dai; Elizabeth E Puscheck; Daniel A Rappolee
Journal:  Stem Cells Dev       Date:  2016-01-29       Impact factor: 3.272

2.  Synergistic inhibition of endochondral bone formation by silencing Hif1α and Runx2 in trauma-induced heterotopic ossification.

Authors:  Lin Lin; Qi Shen; Huijie Leng; Xiaoning Duan; Xin Fu; Changlong Yu
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

3.  Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds.

Authors:  Changqing Xie; Jiang Hu; Haiyun Ma; Jifeng Zhang; Lung-Ji Chang; Y Eugene Chen; Peter X Ma
Journal:  Biomaterials       Date:  2011-03-24       Impact factor: 12.479

4.  Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model.

Authors:  Jie Gong; Yunyun Liu; Tsai-Hua Chung; Liu Xu; Troy C Lund; Lung-Ji Chang
Journal:  Gene Ther       Date:  2022-07-06       Impact factor: 5.250

5.  An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens.

Authors:  Bei Wang; Jin He; Chen Liu; Lung-Ji Chang
Journal:  Vaccine       Date:  2006-02-28       Impact factor: 3.641

6.  Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds.

Authors:  Yongyu Wang; Jiang Hu; Jiao Jiao; Zhongning Liu; Zhou Zhou; Chao Zhao; Lung-Ji Chang; Y Eugene Chen; Peter X Ma; Bo Yang
Journal:  Biomaterials       Date:  2014-07-29       Impact factor: 12.479

7.  RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy.

Authors:  Anne-Kathrin Zaiss; Sodany Son; Lung-Ji Chang
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration.

Authors:  Chen-Xia He; Ding Shi; Wen-Jun Wu; You-Fa Ding; Deng-Min Feng; Bin Lu; Hao-Ming Chen; Ji-Hua Yao; Qi Shen; Da-Ru Lu; Jing-Lun Xue
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 9.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

10.  Overlapping enhancer/promoter and transcriptional termination signals in the lentiviral long terminal repeat.

Authors:  Qing Yang; Aurore Lucas; Sodany Son; Lung-Ji Chang
Journal:  Retrovirology       Date:  2007-01-22       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.